Izba

Izba

travoprost

Manufacturer:

Novartis

Distributor:

DKSH
Concise Prescribing Info
Contents
Travoprost
Indications/Uses
Decrease of elevated IOP in adults w/ ocular HTN or open-angle glaucoma.
Dosage/Direction for Use
Adult including elderly Instill 1 drop into conjunctival sac of affected eye(s) once daily preferably at night. Max: Not to exceed 1 drop daily.
Contraindications
Special Precautions
Possibility of permanent heterochromia, periorbital &/or eyelid skin darkening; increased length, thickness, pigmentation &/or number of lashes. Aphakic patients, pseudophakic patients w/ torn posterior lens cap or anterior chamber lenses; known risk factors for cystoid macular oedema or iritis/uveitis. Avoid skin contact. Remove contact lenses prior to application & wait at least 15 min before reinsertion. May cause skin irritation due to propylene glycol, polyoxyethylene hydrogenated castor oil 40. May affect ability to drive & use machines. Avoid direct exposure in women of childbearing potential or pregnant women. Childn & adolescents <18 yr.
Adverse Reactions
Ocular hyperaemia. Dry eye, eye pruritus, ocular discomfort.
MIMS Class
Antiglaucoma Preparations
ATC Classification
S01EE04 - travoprost ; Belongs to the class of prostaglandin analogues. Used in the treatment of glaucoma.
Presentation/Packing
Form
Izba eye drops 30 mcg/mL
Packing/Price
2.5 mL x 1's
Register or sign in to continue
Asia's one-stop resource for medical news, clinical reference and education
Sign up for free
Already a member? Sign in